Sepsis Biomarkers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Urine Biomarkers, Blood Biomarkers); Application (Diagnostics, Drug Discovery, Personalized Medicine, Others) and Geography

Report Code: TIPRE00023262 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Sepsis is an unusual systemic reaction caused by the body's response to an infection. It is a life-threatening medical emergency. Thus, an early diagnosis of sepsis helps to enable rapid treatment, improve outcomes, and reduce unnecessary antibiotic therapy. Biomarkers can be utilized to diagnose sepsis and allow early intervention, which, although primarily supportive, can reduce the risk of death. These biomarkers help in reducing the mortality rate associated with severe sepsis. Biomarkers are widely used in clinical practice to monitor the infectious process as they can indicate the presence or absence or severity of sepsis and differentiate bacterial from viral and fungal infection and systemic sepsis from a local infection. Presepsin appears to be the most promising biomarker for early diagnosis of sepsis.

MARKET SCOPE

The "Global Sepsis Biomarkers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the sepsis biomarkers market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading sepsis biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global sepsis biomarkers market is segmented into urine biomarkers and blood biomarkers.
  •  On the basis of application, the market is bifurcated into diagnostics, drug discovery, personalized medicine and others.

MARKET DYNAMICS

Drivers

  •  Increasing incidence of sepsis and the need for early detection drive the sepsis biomarkers market.
  •  Increasing diagnostic applications of biomarkers fuel the market growth.
  •  Increasing R&D funding from pharmaceutical and biotech companies propels market growth.

Restraints

  •  Lack of gold standard for sepsis diagnosis (cultures often negative).
  •  Lack of proper testing for a biomarker to assess reliability and validity.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The sepsis biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the sepsis biomarkers market in these regions.

IMPACT OF COVID-19 ON SEPSIS BIOMARKERS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The surge in hospital admission has increased the risk of hospital-acquired infection. A biomarker like Procalcitonin (PCT) plays a vital role in urgent, life-saving early sepsis management. PCT has emerged as a biomarker to aid sepsis diagnosis and improve the clinical assessment of patients. Other sepsis biomarker includes blood lactate measurements, CRP, etc. The usual complications associated with COVID-19 include pneumonia, sepsis or systemic inflammation, and so on. The monitoring of COVID-19 patients takes place by testing biomarkers like CRP, IL6, PCT, and Lactate to assess disease severity and progression and monitor therapeutic intervention. COVID-19 has increased the overall risk of sepsis among the global population that can lead to organ damage. It is shown that elevated PCT levels are positively associated with the severity of COVID-19. Hence, owing to the high susceptibility to the disease, the sepsis biomarker market may witness growth in the future.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the sepsis biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from sepsis biomarkers market are anticipated to have lucrative growth opportunities in the future with the rising demand for sepsis biomarkers in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the sepsis biomarkers market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Thermo Fisher Scientific
  •  Merck
  •  QIAGEN
  •  Roche
  •  Abbott
  •  Bio-Rad Laboratories
  •  Siemens Healthcare
  •  GenMark Diagnostics
  •  T2 Biosystems
  •  Immunexpress

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sepsis Biomarkers Market - By Type
1.3.2 Sepsis Biomarkers Market - By Application
1.3.3 Sepsis Biomarkers Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SEPSIS BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. SEPSIS BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SEPSIS BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. SEPSIS BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. SEPSIS BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. SEPSIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. URINE BIOMARKERS
7.3.1. Overview
7.3.2. Urine Biomarkers Market Forecast and Analysis
7.4. BLOOD BIOMARKERS
7.4.1. Overview
7.4.2. Blood Biomarkers Market Forecast and Analysis
8. SEPSIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTICS
8.3.1. Overview
8.3.2. Diagnostics Market Forecast and Analysis
8.4. DRUG DISCOVERY
8.4.1. Overview
8.4.2. Drug Discovery Market Forecast and Analysis
8.5. PERSONALIZED MEDICINE
8.5.1. Overview
8.5.2. Personalized Medicine Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis

9. SEPSIS BIOMARKERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Sepsis Biomarkers Market Overview
9.1.2 North America Sepsis Biomarkers Market Forecasts and Analysis
9.1.3 North America Sepsis Biomarkers Market Forecasts and Analysis - By Type
9.1.4 North America Sepsis Biomarkers Market Forecasts and Analysis - By Application
9.1.5 North America Sepsis Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Sepsis Biomarkers Market
9.1.5.1.1 Canada Sepsis Biomarkers Market by Type
9.1.5.1.2 Canada Sepsis Biomarkers Market by Application
9.1.5.2 Mexico Sepsis Biomarkers Market
9.1.5.2.1 Mexico Sepsis Biomarkers Market by Type
9.1.5.2.2 Mexico Sepsis Biomarkers Market by Application
9.1.5.3 US Sepsis Biomarkers Market
9.1.5.3.1 US Sepsis Biomarkers Market by Type
9.1.5.3.2 US Sepsis Biomarkers Market by Application
9.2. EUROPE
9.2.1 Europe Sepsis Biomarkers Market Overview
9.2.2 Europe Sepsis Biomarkers Market Forecasts and Analysis
9.2.3 Europe Sepsis Biomarkers Market Forecasts and Analysis - By Type
9.2.4 Europe Sepsis Biomarkers Market Forecasts and Analysis - By Application
9.2.5 Europe Sepsis Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Sepsis Biomarkers Market
9.2.5.1.1 Germany Sepsis Biomarkers Market by Type
9.2.5.1.2 Germany Sepsis Biomarkers Market by Application
9.2.5.2 France Sepsis Biomarkers Market
9.2.5.2.1 France Sepsis Biomarkers Market by Type
9.2.5.2.2 France Sepsis Biomarkers Market by Application
9.2.5.3 Italy Sepsis Biomarkers Market
9.2.5.3.1 Italy Sepsis Biomarkers Market by Type
9.2.5.3.2 Italy Sepsis Biomarkers Market by Application
9.2.5.4 Spain Sepsis Biomarkers Market
9.2.5.4.1 Spain Sepsis Biomarkers Market by Type
9.2.5.4.2 Spain Sepsis Biomarkers Market by Application
9.2.5.5 United Kingdom Sepsis Biomarkers Market
9.2.5.5.1 United Kingdom Sepsis Biomarkers Market by Type
9.2.5.5.2 United Kingdom Sepsis Biomarkers Market by Application
9.2.5.6 Rest of Europe Sepsis Biomarkers Market
9.2.5.6.1 Rest of Europe Sepsis Biomarkers Market by Type
9.2.5.6.2 Rest of Europe Sepsis Biomarkers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Sepsis Biomarkers Market Overview
9.3.2 Asia-Pacific Sepsis Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Sepsis Biomarkers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Sepsis Biomarkers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Sepsis Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Sepsis Biomarkers Market
9.3.5.1.1 Australia Sepsis Biomarkers Market by Type
9.3.5.1.2 Australia Sepsis Biomarkers Market by Application
9.3.5.2 China Sepsis Biomarkers Market
9.3.5.2.1 China Sepsis Biomarkers Market by Type
9.3.5.2.2 China Sepsis Biomarkers Market by Application
9.3.5.3 India Sepsis Biomarkers Market
9.3.5.3.1 India Sepsis Biomarkers Market by Type
9.3.5.3.2 India Sepsis Biomarkers Market by Application
9.3.5.4 Japan Sepsis Biomarkers Market
9.3.5.4.1 Japan Sepsis Biomarkers Market by Type
9.3.5.4.2 Japan Sepsis Biomarkers Market by Application
9.3.5.5 South Korea Sepsis Biomarkers Market
9.3.5.5.1 South Korea Sepsis Biomarkers Market by Type
9.3.5.5.2 South Korea Sepsis Biomarkers Market by Application
9.3.5.6 Rest of Asia-Pacific Sepsis Biomarkers Market
9.3.5.6.1 Rest of Asia-Pacific Sepsis Biomarkers Market by Type
9.3.5.6.2 Rest of Asia-Pacific Sepsis Biomarkers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Sepsis Biomarkers Market Overview
9.4.2 Middle East and Africa Sepsis Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Sepsis Biomarkers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Sepsis Biomarkers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Sepsis Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Sepsis Biomarkers Market
9.4.5.1.1 South Africa Sepsis Biomarkers Market by Type
9.4.5.1.2 South Africa Sepsis Biomarkers Market by Application
9.4.5.2 Saudi Arabia Sepsis Biomarkers Market
9.4.5.2.1 Saudi Arabia Sepsis Biomarkers Market by Type
9.4.5.2.2 Saudi Arabia Sepsis Biomarkers Market by Application
9.4.5.3 U.A.E Sepsis Biomarkers Market
9.4.5.3.1 U.A.E Sepsis Biomarkers Market by Type
9.4.5.3.2 U.A.E Sepsis Biomarkers Market by Application
9.4.5.4 Rest of Middle East and Africa Sepsis Biomarkers Market
9.4.5.4.1 Rest of Middle East and Africa Sepsis Biomarkers Market by Type
9.4.5.4.2 Rest of Middle East and Africa Sepsis Biomarkers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Sepsis Biomarkers Market Overview
9.5.2 South and Central America Sepsis Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Sepsis Biomarkers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Sepsis Biomarkers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Sepsis Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Sepsis Biomarkers Market
9.5.5.1.1 Brazil Sepsis Biomarkers Market by Type
9.5.5.1.2 Brazil Sepsis Biomarkers Market by Application
9.5.5.2 Argentina Sepsis Biomarkers Market
9.5.5.2.1 Argentina Sepsis Biomarkers Market by Type
9.5.5.2.2 Argentina Sepsis Biomarkers Market by Application
9.5.5.3 Rest of South and Central America Sepsis Biomarkers Market
9.5.5.3.1 Rest of South and Central America Sepsis Biomarkers Market by Type
9.5.5.3.2 Rest of South and Central America Sepsis Biomarkers Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. SEPSIS BIOMARKERS MARKET, KEY COMPANY PROFILES
11.1. THERMO FISHER SCIENTIFIC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. QIAGEN
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ROCHE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ABBOTT
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIO-RAD LABORATORIES
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SIEMENS HEALTHCARE
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GENMARK DIAGNOSTICS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. T2 BIOSYSTEMS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. IMMUNEXPRESS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Thermo Fisher Scientific
2.Merck
3.QIAGEN
4.Roche
5.Abbott
6.Bio-Rad Laboratories
7.Siemens Healthcare
8.GenMark Diagnostics
9.T2 Biosystems
10.Immunexpress
TIPRE00023262
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking